A variational approach to optimal two‐stage designs
Abstract
Recalculating the sample size in adaptive two‐stage designs is a well‐established method to gain flexibility in a clinical trial. Jennison and Turnbull (2015) proposed an “optimal” adaptive two‐stage design based on the inverse normal combination test, which minimizes a mixed criterion of expected sample size under the alternative and conditional power. We demonstrate that the use of a combination test is not necessary to control the type one error rate and use variational techniques to develop a general adaptive design that is globally optimal under predefined optimality criteria. This approach yields to more efficient designs and furthermore allows to investigate the efficiency of the inverse normal method and the relation between local (interim‐based) recalculation rules and global (unconditional) optimality of adaptive two‐stage designs.
Citing Literature
Number of times cited according to CrossRef: 5
- Jerzy Adamski, Introduction to metabolomics, Metabolomics for Biomedical Research, 10.1016/B978-0-12-812784-1.00001-3, (1-15), (2020).
- Carolin Herrmann, Maximilian Pilz, Meinhard Kieser, Geraldine Rauch, A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation, Statistics in Medicine, 10.1002/sim.8534, 39, 15, (2067-2100), (2020).
- Maximilian Pilz, Samuel Kilian, Meinhard Kieser, A note on the shape of sample size functions of optimal adaptive two-stage designs, Communications in Statistics - Theory and Methods, 10.1080/03610926.2020.1776875, (1-8), (2020).
- Maximilian Pilz, Meinhard Kieser, Kevin Kunzmann, Comments on “Adaptive sample size modification in clinical trials: Start small then ask for more?”, Statistics in Medicine, 10.1002/sim.8427, 39, 1, (97-98), (2019).
- Christopher Jennison, Bruce W. Turnbull, Authors' reply, Statistics in Medicine, 10.1002/sim.8417, 38, 30, (5670-5671), (2019).
